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Using a novel human colonoid monolayer model, the earliest
targets of enterohemorragic Escherichia coli infection by the
serine protease EspP have been identiﬁed. Mucin-2 and
protocadherin-24 are targeted sequentially, leading to bac-
terial attachment to the epithelium and microvillar
effacement.
BACKGROUND & AIMS: Enterohemorrhagic Escherichia coli
(EHEC) causes over 70,000 episodes of foodborne diarrhea
annually in the United States. The early sequence of events that
precede life-threatening hemorrhagic colitis and hemolytic
uremic syndrome is not fully understood due to the initial
asymptomatic phase of the disease and the lack of a suitable
animal model. We determined the initial molecular events in
the interaction between EHEC and human colonic epithelium.
METHODS: Human colonoids derived from adult proximal
colonic stem cells were developed into monolayers to study
EHEC-epithelial interactions. Monolayer conﬂuency and differ-
entiation were monitored by transepithelial electrical resis-
tance measurements. The monolayers were apically infected
with EHEC, and the progression of epithelial damage over time
was assessed using biochemical and imaging approaches.
RESULTS: Human colonoid cultures recapitulate the differential
protein expression patterns characteristic of the crypt and sur-
face colonocytes. Mucus-producing differentiated colonoid
monolayers are preferentially colonized by EHEC. Upon coloni-
zation, EHEC forms characteristic attaching and effacing lesions
on the apical surface of colonoid monolayers. Mucin 2, a main
component of colonic mucus, and protocadherin 24 (PCDH24), a
microvillar resident protein, are targeted by EHEC at early
stages of infection. The EHEC-secreted serine protease EspP
initiates brush border damage through PCDH24 reduction.
CONCLUSIONS: Human colonoid monolayers are a relevant
pathophysiologic model that allow the study of early molecular
events during enteric infections. Colonoid monolayers provide
access to both apical and basolateral surfaces, thus providing
an advantage over three-dimensional cultures to study
host–pathogen interactions in a controllable and tractable
manner. EHEC reduces colonic mucus and affects the brushborder cytoskeleton in the absence of commensal bacteria. (Cell
Mol Gastroenterol Hepatol 2016;2:48–62; http://dx.doi.org/
10.1016/j.jcmgh.2015.10.001)
Keywords: Human Colonoid Monolayers; Intestinal Organoids;
Microvillar Effacement; Serine Protease EspP.
higa toxin–producing enterohemorrhagic EscherichiaS coli (EHEC) is the major disease-causing food borne
E. coli, withw73,000 illnesses,w3000 hospitalizations, and
w500 deaths annually in the United States.1 In humans,
EHEC colonizes the ascending colon and causes watery
diarrhea that can progress into hemorrhagic colitis, and in
w10% of patients causes life-threatening extraintestinal
complications, including hemolytic uremic syndrome
(HUS).2 There is currently no treatment available for EHEC
infections3 because drugs commonly used to treat bacterial
infections, such as antibiotics, antimotility agents, and nar-
cotics, promote HUS development.4
The absence of a speciﬁc treatment is partially due to the
lack of animal or cell culturemodels that fully recapitulate the
disease. Thus far, studies that have used carcinoma-derived
human intestinal epithelial cell lines have had low impact
due to their transformed phenotype.5 Animal models have
been developed to study the pathogenesis of EHEC infection
January 2016 Human Colonoids as a Model for EHEC Infection 49in vivo but do not mimic all aspects of EHEC-induced disease
in humans. For example, rabbits exhibit some of the gastro-
intestinal characteristics of human EHEC-induced disease,
including bloody diarrhea, but do not develop HUS.6
Upon interaction with the human intestinal epithelium,
EHEC implements two major virulence strategies: produc-
tion of Shiga toxins (Stx) and formation of attaching and
effacing (A/E) lesions on enterocytes.7 A/E lesions are
characterized by extensive actin remodeling of the host cell
cytoskeleton, leading to effacement of the microvilli and
formation of an F-actin pedestal-like structure beneath
the bacteria.8 Improved understanding of the basis for EHEC
pathogenicity is of increasing importance given the growing
number of outbreaks worldwide. An infection model that
recapitulates the human pathophysiology of EHEC infection
is necessary for the development of therapeutic strategies
for these currently untreatable conditions.
Stx is the main virulence factor in EHEC infection;
however, Stx’s effects are most potent in the circulatory and
renal systems. Other known EHEC virulence factors that act
upon the intestinal epithelium include intimin, tir, and the
serine protease autotransporters of Enterobacteriaceae
(SPATE) family. EspP is a major SPATE secreted by EHEC
via the type V secretion system at the early stage of infec-
tion.9,10 Although EspP’s primary functions in EHEC-induced
disease are not well understood, previous studies on the
SPATE family have reported that they cause host cytotox-
icity and cleave actin-bound cytoskeletal proteins, causing
massive actin rearrangement.11 Using the intestinal epithe-
lial T84 cell model, we have previously shown that recom-
binant EspP is sufﬁcient to trigger the described actin
remodeling.12 Therefore, we hypothesized that EspP plays a
major role in promoting EHEC pathogenicity.
Recent progress in human stem cell biology, particularly
the technology to establish and indeﬁnitely propagate an
intestinal epithelial culture,13 opens new possibilities for
studying EHEC interaction with human intestinal epithe-
lium, the ﬁrst step in disease development. These cultures,
termed enteroids or colonoids, typically grow as three-
dimensional (3D) spheres with the apical surface facing
inward. They are not ideal for studying the interaction be-
tween luminal gut bacteria and epithelial cells because the
lumen is not easily accessible. We and others have recently
pioneered human enteroid monolayer cultures grown on
Transwell ﬁlters in which the apical surface faces outward
and the basolateral surface is attached to the ﬁlter.14,15
These human monolayer cultures provide an advantage in
studying luminal infections and testing strategies for lumi-
nally delivered pharmacologic agents to interfere with
intestinal epithelial infections.
Here we report the method for establishing colonoid
monolayers derived from the human proximal colon as a
model of EHEC infection. We show that extracellular mucin
2 (MUC2) and the brush border (BB) resident protein pro-
tocadherin 24 (PCDH24) are initial targets of EHEC during
infection. We determined that the EHEC virulence factor
EspP, speciﬁcally its protease activity, is responsible for
PCDH24 reduction. We conclude that human colonoid
monolayers (HCM) are a suitable model to study EHECintestinal colonization and to characterize the molecular
mechanisms of host-EHEC interactions.
Materials and Methods
All authors had access to the study data and reviewed
and approved the ﬁnal manuscript. All human tissue was
obtained with informed consent from healthy individuals at
the Johns Hopkins Hospital and coded with no patient
identiﬁers. This study was approved by the Johns Hopkins
institutional review board protocol (NA_0038329).
Reagents and Antibodies
Advanced Dulbecco’s modiﬁed Eagle medium/Ham’s F12,
HEPES, GlutaMAX, B27 supplement minus vitamin A, N2
supplement, epidermal growth factor, Alexa Fluor 568 Phal-
loidin, 40,6-diamidino-2-phenylindole, Tris-acetate gradient
gels, Tris-glycine gradient gels, and monoclonal antibody
against occludin were purchased from Life Technologies
(Carlsbad, CA). Penicillin/streptomycin was purchased from
Quality Biological (Gaithersburg, MD). Matrigel, Cell Recov-
ery Solution, and the Transwell ﬁlter inserts were purchased
from Corning (Tewksbury, MA). Jagged-1 and [Leu-15]
gastrin were purchased from AnaSpec (Fremont, CA). N-
acetylcysteine, prostaglandin E2, collagen IV from human
placenta, protease inhibitor cocktail, and polyclonal anti-
bodies against PCDH24, GAPDH, and sodium-hydrogen
exchanger regulatory factor 3 (NHERF3) were pur-
chased from Sigma-Aldrich (St. Louis, MO). A83-01
[3-(6-methylpyridin-2-yl)-N-phenyl-4-quinolin-4-ylpyrazole-
1-carbothioamide], Y-27632 [4-[(1R)-1-aminoethyl]-N-
pyridin-4-ylcyclohexane-1-carboxamide], and CHIR99021
[6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)
pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile]
were purchased from Tocris (Bristol, UK). Primocin was
purchased from Invivogen (San Diego, CA). Polyclonal anti-
body against sodium-hydrogen exchanger isoform 2 (NHE2)
was kindly provided by Dr. C. Ming Tse (Johns Hopkins
University, Baltimore, MD). Polyclonal antibody against EspP
was kindly provided by Dr. Harris Bernstein (National In-
stitutes of Health, Bethesda, MD). Monoclonal antibody
against Muc2 and polyclonal antibody against phosphory-
lated ezrin were purchased from Abcam (Cambridge, MA).
IRDye-conjugated secondary antibodies were purchased
from Rockland (Limerick, PA). Wnt3A (American Type Cul-
ture Collection, Manassas, VA), R-spondin1 (kindly provided
by Dr. Calvin Kuo, Stanford University, Stanford, CA), and
Noggin16 (kindly provided by Dr. Marcel Bijvelds, Erasmus
University, Rotterdam, the Netherlands) cell lines were
maintained to produce conditioned media.
Generation and Culturing of
Colonoid Monolayers
Proximal colonic crypts isolated from tissue resections or
biopsies were processed for colonoid generation as described
for small intestinal enteroids.13,14 Brieﬂy, colonic tissue was
collected in sterile phosphate-buffered saline (PBS) and kept
on ice. The tissue was then transferred into cold chelating
solution (CCS; 5.6mMNa2HPO4, 8mMKH2PO4, 96.2mMNaCl,
50 In et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 11.6mMKCl, 43.4mMsucrose, 54.9mMD-sorbitol, and 0.5mM
DL-dithiothreitol) andﬁnelyminced to approximately 0.5-mm
pieces using curved surgical scissors. The tissue pieces were
transferred to a 15-mL conical tube with fresh CCS and
allowed to settle by gravity. The supernatant was removed,
fresh CCS was added, and the tissue pieces triturated to
simulate washing. This process was performed ﬁve times or
until the supernatant was completely cleared of debris.
The tissue pieces were then incubated in 10 mM EDTA in
CCS for 1 hour at 4C, during which they were vigorously
shaken on an orbital shaker. Afterward, the tissue pieces
and supernatant were collected in a 15-mL conical tube, and
fetal bovine serum (ﬁnal concentration of 20%) was added
to create buoyancy and allow the released crypts to remain
in the supernatant while the tissue pieces settled to the
bottom. The crypt-rich supernatant was collected and spun
at 300g for 10 minutes to pellet the crypts. The crypt pellet
was washed with complete medium (CM; Advanced Dul-
becco’s modiﬁed Eagle medium/Ham’s F-12, 100 U peni-
cillin/streptomycin, 10 mM HEPES, and 0.2 mM GlutaMAX)
and spun down. The crypt pellet was resuspended in
Matrigel containing 1 mM Jagged-1 peptide.
Approximately 100 crypts per 50 mL Matrigel were plated
into an individual well of a 24-well plate and placed at 37C
for 10–15 minutes to polymerize. Each well received 500 mL
of expansion medium (EM) The EM was CM containing
50% v/v Wnt3a conditioned medium, 20% v/v R-spondin-1
conditioned medium, 10% v/v Noggin conditioned medium,
1x B27 supplementminus vitamin A, 1x N2 supplement, 1mM
N-acetylcysteine, 50 ng/mL human epidermal growth factor,
1 mg/mL [Leu-15] gastrin, 500 nM A83-01, 10 mM SB202190
[4-[4-(4-ﬂuorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-
ylidene]cyclohexa-2,5-dien-1-one], 10 nM prostaglandin E2,
100 mg/mL primocin, 10 mMCHIR99021, and 10 mMY-27632.
The EM (without CHIR99021 and Y-27632) was replaced
every other day.Colonoid Expansion, Monolayer
Formation and Differentiation
Colonoids were passaged approximately every 7 to 10
days by incubation in Cell Recovery Solution (nonenzymatic
proprietary solution purchased from Corning) for 15 to 20
minutes at 4C with vigorous shaking on an orbital shaker.
The colonoids in Matrigel were scraped using a mini-cell-
scraper and triturated with a P200 pipet 20–30 times to
break colonoids apart into fragments. They were then
collected and centrifuged at 300g for 10 minutes, then the
pellet was resuspended in Matrigel containing 1 mM Jagged-
1 peptide. The pellet was split to generate a minimum of
50 colonoids per well post-split. Each well received 500 mL
of EM with CHIR99021 and Y-27632 on the day they were
split, but they were refreshed with EM without CHIR99021
and Y-27632 on the following days.
To form colonoid monolayers, Transwell ﬁlters (24-well
inserts, 0.33 cm2 surface area, 0.4 mM pore polyester
membrane) were coated with human collagen IV solution
(ﬁnal concentration of 10 mg/cm2) and incubated at 37C
for a minimum of 2 hours. Per manufacturer’s suggestion,the lyophilized collagen IV was reconstituted with sterile
0.25% acetic acid for a stock concentration of 1 mg/mL.
This solution was diluted in sterile, DNAse- and RNAse-free
water for plating at a ﬁnal concentration of 10 mg/cm2.
Before plating of colonoid fragments, the collagen-coated
Transwell ﬁlters were washed three times with CM. Colo-
noid fragments were obtained by following the passaging
procedure. After centrifugation, the pellet was resuspended
in EM at a ratio of approximately 50 colonoid fragments per
100 mL EM. We added 100 mL EM/colonoid fragment solu-
tion to each Transwell ﬁlter and allowed it to settle at 37C.
EM was also added to the well of each ﬁlter, representing
the basolateral media. Both media were exchanged every
other day, and spreading of the colonoids into a two-
dimensional monolayer was monitored with a Zeiss AXIO
light microscope (Zeiss, Oberkochen, Germany). Conﬂuency
of monolayers was determined by transepithelial electrical
resistance (TER) measured by the EVOM2 epithelial volt
ohmmeter (World Precision Instruments, Sarasota, FL).
Infection of Colonoids
Infection of colonoids was performed with the following
strains: 1) EHEC O157:H7 strain EDL933 modiﬁed to be Stx-
negative, 2) EDL933 espP-deletion mutant (EHECDespP), 3)
EHECDespP complemented with an espP-expressing
plasmid (EHEC þ pespP), and 4) EDL933 stcE-deletion
mutant (EHECDstcE). Bacterial strains were grown by
shaking in Lysogeny broth (LB) broth at 37C for 12 hours
to the stationary phase, then centrifuging at 200g and
resuspending in antibiotic-free EM. The colonoids were
infected apically at bacterial concentrations of 106 colony-
forming units/mL and incubated at 37C in 5% CO2 for 4,
8, or 18 hours, during which period the medium was not
changed. After the predetermined time point, the colonoids
were washed three times with cold PBS and ﬁxed for
immunoﬂuorescence or lysed for immunoblotting.
Bacterial Strains, Plasmids,
and Factors
In-frame deletion mutants were constructed in the EHEC
O157:H7 strain EDL933 Shiga toxin-deleted derivative
TUV93-017 by Lambda Red-mediated recombination using
linear DNA fragments as described elsewhere.37 Brieﬂy,
DNA fragments encoding a kanamycin resistance cassette
ﬂanked by Flipase Recognition Target site-inverted repeats
and sequences homologous to regions ﬂanking espP or stcE
were polymerase chain reaction (PCR) ampliﬁed from,
respectively, pKD13 and pKD4 using primer sets AH1253/
AH1254 and AH1322/AH1323 by the high-ﬁdelity DNA
polymerase EasyA (Agilent Technologies, Santa Clara, CA).
DNA fragments were electroporated into TUV93-0, where
the Red recombinase system was expressed from pKD46.
Recombinants were selected and puriﬁed on L-agar plates
containing 50 mg/mL kanamycin. The kanamycin resistance
marker was eliminated from EHEC DespP::kan and EHEC
DstcE::kan using a pCP20-encoded FLP ﬂipase,18 resulting
in EHEC DespP (AMH 194) and EHEC DstcE (AMH 196).
Gene deletions of espP and stcE were veriﬁed by PCR
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and AH1324/AH1325, respectively. The complementation
plasmid pAMH351 expressing espP from its native promoter
was generated by cloning a DNA fragment, which was PCR
ampliﬁed from a TUV93-0 genomic DNA preparation with
high-ﬁdelity DNA polymerase Phusion Flash (Thermo Sci-
entiﬁc, Waltham, MA) using primers AH1256/AH1327, into
the BamHI/HindIII sites of the low copy number plasmid
pSec10. EDL933 T3SS deletion mutant of E. coli–secreted
protein A (DespA) was constructed by in-frame deletion as
we previously described elsewhere.12
The oligonucleotide sequences used were AH1253: 50-
CATTAGAAAAACCAATGTTTCCCTTAAAAATGGAGCTTATGTC
CGGGGATCCGTCG ACCT-30; AH1254: 50-GAGCGTAAAGGGCC
CGCAGGCCCTTTTGAATACGGAGTAGTGTAGGCTGGAGCTG C
TTCG-30; AH1255: 50-CACTGCGGCCGCTTATTATGCTTCCAT
CAGAAACGATG-30; AH1256: 50-CACTGGATCCTGCCAGCTT
TAGTCATCGCAGTTAAG-30; AH1322: 50-AATAAAATATAGA
AATACTGTTATATCCGGCTGCATGTTGGTGTAGGCTGGAGCTG
CTTC-30; AH1323: 50-TTATTTATATACAACCCTCATTGACCTA
GGTTTACTGAAGCATATGAATATCCTCCT TAG-30; AH1324:
50-CATGTAAGCTTGAATGTATCATAATGCAATTGTTTGATGTG
TTAAACG-30; AH1325: 50-CATGTAAGCTTACGAATGTGT
TACTAATGCGGCCGA-30; and AH1327: 50-CAGAAAAAGCT
TATTATGCTTCCATCAGAAAC-30.
Genes encoding full-length EspP and serine protease
mutant EspP S263A were cloned into the pRLS5 plasmid
under the control of an isopropyl b-D-1-thiogalactopy
ranoside–inducible promoter as previously described else-
where.19 The plasmids were transduced into the E. coli strain
AD202. EspP or EspP S263Awas expressed upon isopropyl b-
D-1-thiogalactopyranoside inductionandprecipitated fromthe
supernatant with 60% ammonium sulfate. The recombinant
proteins were concentrated by centrifugation, solubilized in
PBS, and puriﬁedon a gelﬁltration column. Recombinant EspP
and EspP S263A were veriﬁed by sequencing and Coomassie
blue staining. The ﬁnal protein concentration was determined
by BCA colorimetric assay. Colonoids were treated apically
with recombinant EspP or EspP S263A at a maximum con-
centration of 10 mM for 5 hours. Afterward, cells were washed
three times with cold PBS and lysed for immunoblotting.Immunoﬂuorescence
Colonoid monolayers on ﬁlters were ﬁxed with 3%
formaldehyde/PBS for 10 minutes, washed three to four
times with PBS, permeabilized with 0.1% saponin, and
blocked with 2% bovine serum albumin/fetal bovine serum
for 30 minutes. For MUC2 labeling, colonoid monolayers
were ﬁxed in Carnoy’s solution (90% [v/v] methanol, 10%
[v/v] glacial acetic acid). The cells were then immunostained
with the following antibodies: MUC2 (1:100), PCDH24
(1:100), ﬂuorescence Alexa Fluor secondary antibody,
Hoechst (1 mg/mL), Alexa Fluor 568 Phalloidin (1:200), and
ﬂuorescein labeled EHEC antigen (1:100).
The ﬁlters were carefully removed by cutting the ﬁlter
away from the insert, then immersed in gel mount and
mounted onto glass slides. Fluorescence confocal imaging
was performed using a Zeiss 510 LSM (Zeiss, Oberkochen,Germany). The images were quantitatively and qualitatively
analyzed using MetaMorph software (Molecular Devices,
Sunnyvale, CA).
Western Blot Analysis
Colonoid monolayers were washed three to four times
with cold PBS then carefully dried by inverting the ﬁlter
insert and tapping to remove excess ﬂuid and to preserve
the MUC2-positive mucus layer. The cells were harvested in
lysis buffer (60 mM HEPES pH 7.4, 150 mM KCl, 5 mM
Na3EDTA, 5 mM EGTA, 1 mM Na3VO4, 50 mM NaF,
1% Triton X-100) with protease inhibitor cocktail (1:100)
and disrupted by vigorous pipetting with a P200 tip, fol-
lowed by ﬂash freeze in liquid N2, then end-over-end
rotation at 4C for 2 hours. One conﬂuent colonoid mono-
layer consisted of approximately 120 mg of protein. Lysates
were further solubilized in sodium dodecyl sulfate gel-
loading buffer with b-mercaptoethanol or with dithio-
threitol (for MUC2). Lysates were heated at 70C for
10 minutes, and then the proteins were separated by so-
dium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) on Tris-glycine or Tris-acetate (for MUC2) gels
and transferred to nitrocellulose membranes.
After transfer, membranes were blocked in 5%milk/Tris-
buffered saline (TBS)-Tween (0.1%) at 25C for 1 hour, then
incubated with primary antibodies at 4C overnight. The
primary antibodies used were occludin (1:250), NHE2
(1:500), NHERF3 (1:250), PCDH24 (1:500), MUC2 (1:500),
GAPDH (1:1000), and EspP (1:500). Membranes were
washed ﬁve times for 5 minutes each with TBS-Tween
(0.1%) then incubated with IRDye-conjugated secondary
antibodies at 25C for 1 hour. Membraneswere againwashed
ﬁve times for 5 minutes each with TBS-Tween (0.1%) then
imaged using a Li-Cor Odyssey system infrared imaging
scanner (Li-Cor, Lincoln, NE). Relative ﬂuorescence intensity
of the target protein was normalized to the ﬂuorescence in-
tensity of GAPDH, as previously described elsewhere.20
Real-Time Polymerase Chain Reaction
Two colonoid monolayers grown on Transwells were
pooled for total RNA extraction. RNA extraction was per-
formed using the PureLink RNA Mini Kit (Life Technologies,
Carlsbad, CA). SuperScript III Reverse Transcriptase (Life
Technologies) was used to synthesize cDNA. The LGR5
(leucine-rich repeat containing G protein-coupled receptor
5) primer (purchased from Life Technologies) was previ-
ously described elsewhere.21 The PCR reactions were per-
formed with Power Sybr Green master mix (Life
Technologies) on a QuantStudio 12K Flex (Life Technolo-
gies). Relative expression for both undifferentiated and
differentiated conditions was normalized to the internal
control, RN18S, and averaged over three independent
experiments and three separate colonoid lines.
Scanning and Transmission
Electron Microscopy
Monolayers were ﬁxed overnight at 4C and processed
for scanning electron microscopy as described elsewhere.20
Table 1.Transepithelial Electrical Resistance of Human
Colonoid Monolayers (U$cm2)
Monolayers TER No.
Undifferentiated uninfected 213 ± 7a 12
Differentiated uninfected 1368 ± 61a 15
Differentiated infected
4 h 1354 ± 86 12
8 h 1049 ± 118 12
aP < .05.
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0.1 M sodium cacodylate at 4C for 1 hour. Filters were
dehydrated through a graded series of ethanol and passed
through pure hexamethyldisilazane. The drying agent was
decanted, and ﬁlters were desiccated overnight. Filters were
attached to aluminum stubs via carbon sticky tabs and
coated with 20-nm AuPd. The stubs were viewed and im-
ages captured on a LEO 1530 ﬁeld emission scanning elec-
tron microscope (LEO Electron Microscopy/Carl Zeiss,
Thornwood, NY) operating at 1–3 kV.
Monolayers were processed for transmission electron
microscopy as previously described elsewhere.12 Brieﬂy,
ﬁlters were ﬁxed for 2 hours in solution containing
2% glutaraldehyde, 2% paraformaldehyde, 0.1 M Na-
cacodylate, 3 mM CaCl2, pH 7.4 at room temperature. Fil-
ters were incubated in 1% H2O2 for 1 hour then post-ﬁxed
in 2% osmium tetroxide in 0.1 M Na-cacodylate for 1 hours
then placed in 2% uranyl acetate for 1 hour. After en-bloc
staining, ﬁlters were dehydrated through a graded series
of ethanol to 100%, transferred through propylene oxide,
embedded in Eponate 12 (Ted Pella, Redding, CA) and cured
at 60C for 2 days. Sections of 80 nm were cut on a Reichert
Ultracut E (Leica Microsystems, Buffalo Grove, IL) with a
Diatome Diamond knife (Diatome, Hatﬁeld, PA) then
collected on Formvar coated 1  2 mm copper slot grids
and stained with uranyl acetate followed by lead citrate.
Grids were viewed and captured on a Hitachi 7600 trans-
mission electron microscope (Hitachi High Technologies
America, Schaumburg, IL) operating at 80 kV.
Statistical Analysis
Values are presented as mean ± standard error of the
mean, with n representing number of independent prepa-
rations. Statistical signiﬁcance was determined using the
Student unpaired t test, and P < .05 was considered sta-
tistically signiﬁcant.
Results
Establishment of Human Proximal
Colonoid Monolayer Cultures
Cultures of 3D Matrigel-grown colonoids (cultures ob-
tained from ﬁve separate donors) were converted into
monolayers. Approximately 200 colonoids were recovered
from the Matrigel culture and were seeded on Transwell
ﬁlters (0.33 cm2) coated with human collagen IV (10 mg/
cm2). Conﬂuent HCM were achieved approximately 2 weeks
after seeding. HCM were differentiated to produce a culture
consisting of surface-like colonocytes and goblet cells by
withdrawal of WNT3A from the growth medium for 5 days,
as has been previously described elsewhere.13,22 The cell
polarization and formation of conﬂuent undifferentiated
monolayers were documented by a signiﬁcant and sustain-
able increase in transepithelial electrical resistance (TER),
while differentiation induced an even greater increase in
TER (Table 1). Differentiation led to a signiﬁcant increase in
a number of proteins that are enriched in surface colono-
cytes and at the top of crypts,23 including occludin, NHE2,
NHERF3, and the goblet cell marker MUC2, as shown byimmunoblots (Figure 1A). In contrast, there was a signiﬁ-
cant decrease in the stem cell marker LGR5 (Supplementary
Figure 1). The differential expression of the surface and
crypt markers were veriﬁed in all ﬁve proximal colonoid
lines generated from different donors throughout the course
of this study.
Colonoid differentiation was also characterized by
signiﬁcantly enhanced BB organization (see Figure 1B). In
undifferentiated HCM, colonocyte microvilli were sparse
and variable in height. After differentiation, HCM exhibited
tightly packed microvilli (10–15 microvilli per 1 mm of
membrane) that were w1 mm tall. Intestinal epithelial cell
(IEC) differentiation and BB organization are accompanied
by the formation of a regular network of intermicrovillar
bridges.24 PCDH24 is an essential building block of these
bridges and is necessary for the tight packing, clustering,
and uniformity of microvillar length during BB assembly.
Indeed, PCDH24 expression was signiﬁcantly increased
upon HCM differentiation (see Figure 1A), similar to the
surface expression of PCDH24 in human tissue from the
proximal colon. Numerous intermicrovillar bridges were
detected in the BB of differentiated HCM (see Figure 1B),
consistent with the important role of PCDH24 in BB struc-
tural organization described by Crawley et al.24 We
conclude that HCM recapitulate essential features of the
adult human colonic epithelium.Enterohemorrhagic Escherichia coli
Preferentially Colonizes the Differentiated
Human Colonoid Monolayers
To determine whether colonic epithelial differentiation
plays a role in initial EHEC colonization, we infected both
undifferentiated and differentiated HCM with equal con-
centrations of EHEC (106) for 8 hours, then compared the
number of EHEC bacteria associated with the apical surface
of differentiated versus undifferentiated HCM. The number
of EHEC associated with the surface of differentiated
monolayers (Figure 2B) wasw6-fold higher (see Figure 2D)
compared with undifferentiated (see Figure 2A), indicating
that differentiation might play an important role in EHEC
interaction with host epithelium. To test the speciﬁcity of
colonic differentiation in EHEC colonization, we infected
differentiated human enteroid monolayers derived from
jejunal stem cells with the same EHEC concentration for 8
hours and found few bacteria attached (see Figure 2C),
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Figure 2. Enterohemorrhagic Escherichia coli (EHEC) preferentially colonize differentiated colonoid monolayers. (A)
Representative confocal three-dimensional projections from images of undifferentiated and (B) differentiated human
colonoid monolayers (HCM) infected with 106 EHEC for 8 hours. Phalloidin (red), DNA (blue), EHEC antigen (green). Bars:
10 mM. (C) Representative confocal three-dimensional projection from images of differentiated jejunal monolayers infected
with 106 EHEC for 8 hours. Very few EHEC were found attached or associated. Phalloidin (red), EHEC antigen (green). Bar:
10 mM. (D) Quantiﬁcation of EHEC or EHECDespA bacteria associated with undifferentiated and differentiated colonic
monolayers. Twenty separate ﬁelds (each measuring 50  50 mm) were counted for EHEC and averaged. EHECDespA were
counted in 12 separate ﬁelds (each measuring 50  50 mm) and averaged (n ¼ three independent experiments). **P < .001;
*P < .05.
54 In et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 1indicating that colon-speciﬁc differentiation plays an
important role in EHEC colonization.
One of the striking differences between surface colonic
versus villus small intestinal epithelium is the presence of
thick, nearly impenetrable luminal mucus.25 Thus, we tested
the effect of EHEC infection on colonic mucus.Figure 1. (See previous page). Removal of Wnt3A induces d
marker in both undifferentiated and differentiated colonoids no
signiﬁcant increase, P < .05, n ¼ 3. Protein expression chan
differentiation. (B) Scanning electron microscope (SEM) images
low magniﬁcation show the uniform mucus-covered brush bord
and uneven BB of the undifferentiated monolayers. (C) Scannin
entiated colonoid monolayers at higher magniﬁcation show dis
induced by differentiation.Human Colonoid Monolayers Produce a Mucus
Layer That Is Destroyed by Enterohemorrhagic
Escherichia coli Infection
To attach to human IEC, EHEC must penetrate the two
layers of colonic mucus: the inner attached layer and the
loose (gel) outer layer. Mucus consists primarily of a mixtureifferentiation of colonoids. (A) The relative amount of each
rmalized to GAPDH as shown in Western blots. *Statistically
ges show transition to surface colonocyte population upon
of undifferentiated and differentiated colonoid monolayers at
er (BB) in differentiated monolayers compared with the sparse
g electron microscope images of undifferentiated and differ-
tinct changes in the BB and microvillar height (lower panel)
Figure 3. Enterohemorrhagic Escherichia coli (EHEC) infection targets the mucus layer in human colonoids. (A, B)
Differentiated human colonoid monolayers (HCM) express a thick (>25 mm) inner mucus layer primarily composed of MUC2
(red). DNA (blue). (A) XY projection; (B) XZ projection. (C, D) EHEC infection for 4 hours reduces thickness of the extracellular
mucin 2 (MUC2)–positive mucus layer. Remaining MUC2 (red) is intracellular in goblet cells. Arrows point to attached EHEC
(green). (C) XY projection; (D) XZ projection . (E–G) Scanning electron microscope images of HCM (E) uninfected and (F, G)
EHEC-infected after 6 hours. EHEC infection leads to microvillar effacement and apical membrane perturbation (F) and EHEC
attachment to the remaining glycocalyx (G).
January 2016 Human Colonoids as a Model for EHEC Infection 55of large, highly glycosylated proteins called mucins (MUCs),
which are secreted by goblet cells. The inner layer consists of
transmembrane mucins and the major colonic gel mucin
MUC2, and the outer layer mainly contains MUC2.25,26
Differentiated HCM expressed MUC2-producing goblet
cells and formed a 25 mm thick layer of MUC2-containing
apical mucus (Figure 3A and B), indicating active mucus
secretion, comparable to that of the human colon. This
mucus layer was absent from undifferentiated HCM or
differentiated jejunal monolayers (data not shown), similar
to what has been reported in human tissue.25,26
We tested the effect of EHEC infection on the amount
and distribution of MUC2. Infection of colonoid monolayers
with EHEC (106) for 4 hours caused signiﬁcant reduction of
the MUC2-positive mucus layer, with MUC2 restricted
mainly to goblet cells (Figure 3C and D) and small patches at
the cell surface. The decrease in mucus layer thickness
allowed bacteria to reach the apical surface of the colono-
cytes and colonize the epithelium (see Figure 3C and D).
These data suggest that EHEC reduces colonic mucus to
increase its proximity to the colonocyte surface, which
allows EHEC to directly interact with host IEC.Scanning electron microscopy further showed that the
HCM apical surface is covered with a thick layer of mucus
(see Figure 3E). However, 4 hours after infection, the apical
surface was perturbed, and EHEC were attached (see
Figure 3F). In addition, we observed a tight association of
EHEC with patches of the remaining mucus layer by hun-
dreds of threadlike structures (see Figure 3G), likely cor-
responding to the reported bacterial ﬁbrillar network.27
These data suggest that the colonic mucus layer may pro-
mote the initial colonization of the host epithelium.
We next investigated how EHEC destroys the mucus layer
and gains access to the HCM apical surface. It was previously
suggested that the zinc metalloprotease StcE, secreted by
EHEC O157:H7, contributes to intimate adherence of bacteria
to host cells by cleavage of heavily glycosylated mucin layer
proteins, thereby allowing the pathogen to come into close
proximity with the host cell membrane.28 However, StcE was
shown to speciﬁcally target orally expressed MUC7,29 and its
role in the reduction of MUC2-positive mucus in non-
transformed human colonic epithelial cells is unknown.29
Therefore, we tested whether StcE contributes to EHEC-
induced reduction of the MUC2-positive mucus layer in HCM.
Figure 4. Enterohemorrhagic Escherichia coli (EHEC)
DstcE is able to degrade the human colonoid monolayers
(HCM) mucus layer. (A) Representative confocal three-
dimensional projection from images of EHECDstcE-infected
HCM shows that EHECDstcE infection does not prevent the
extracellular mucin 2 (MUC2)–positive mucus layer reduction.
Remaining MUC2 (red) resides intracellularly in goblet cells.
EHEC antigen (green), DNA (blue). Bar: 10 mM. (B) MUC2
expression normalized to GAPDH is signiﬁcantly decreased
(*P < .05) in EHEC and EHECDstcE infected colonoids
compared with uninfected.
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stcE (EHECDstcE) resulted in a mucus layer reduction
(Figure 4A), suggesting that StcE is not essential for MUC2
reduction or is functionally redundant. Numerous bacteria
were associated with the mucus-free apical surface, and
MUC2 was detected only in small patches at the cell surface
(see Figure 4A), similar to what we observed upon infection
with the parental EHEC strain (see Figure 3C and D).Enterohemorrhagic Escherichia coli Damages
the Brush Border of Human Colonocytes Beyond
the Areas of Attaching and Effacing Lesions
In areas of complete mucus reduction there was
signiﬁcant damage to BB organization, with a substantial
decrease in the amount and height of microvilli (Figure 5A).
With mucus reduction, EHEC is able to efface microvilli,
forming characteristic A/E lesions (see Figure 5B) that are
not seen on uninfected HCM (see Figure 5D). The sites of
bacterial attachment were accompanied by characteristic
F-actin pedestals (see Figure 5C), which were also detected
by scanning electron microscopy (see Figure 5A, inset).To show the signiﬁcance of the T3SS in EHEC coloniza-
tion of HCM, we used the EHECDespA mutant, which lacks
T3SS activity, as we have described elsewhere.12 EspA en-
codes the translocation ﬁlament that delivers multiple T3SS
effectors, including the intimin receptor tir, into host
epithelial cells.1 Infection of HCM with EHECDespA signiﬁ-
cantly decreased the number of attached bacteria compared
with infection with parental EHEC (see Figure 2D), similarly
to EHEC infection of human colonic biopsies.30
Importantly, the damage to the epithelial monolayer was
much broader and was not restricted to the sites of A/E
lesions. Overall, the whole monolayer was signiﬁcantly
damaged, including the apical and lateral membranes (see
Figure 5E), further conﬁrming observations by ourselves
and others that EHEC-induced damage of intestinal cells is
not limited to cells that directly interact with EHEC through
A/E lesions.31Enterohemorrhagic Escherichia coli Targets
the Protocadherin 24–Containing
Intermicrovillar Bridges
A signature of EHEC infection is the loss of microvilli,
which occurs throughout the epithelium and not only in
places of bacterial A/E.31 However, the mechanism for BB
effacement is poorly understood. It has been shown that
loss of PCDH24, a major building block of intermicrovillar
bridges, gives rise to BBs that appear disorganized, sparse,
and have a highly variable microvillar length,24 similar to
what we found with EHEC infection (see Figure 5A). We
thus hypothesized that the loss of PCDH24 and inter-
microvillar bridges may be an initial step in EHEC-induced
global BB damage.
We ﬁrst determined the expression pattern of PCDH24
in human colonic tissue and tested whether differentiated
HCM express PCDH24 in a similar pattern. PCDH24
expression was very much restricted to terminally differ-
entiated surface cells and was not detected in the upper
crypts (Figure 6A). Similarly, PCDH24 expression in differ-
entiated HCM was detected in patches of cells, likely rep-
resenting the differentiated surface colonocytes in the
monolayer (see Figure 6B) with the PCDH-negative cells
representing the upper crypt cells. PCDH24 was expressed
mainly at the apical surface of epithelial cells, including the
cell perimeter.
We assessed the effect of EHEC infection on expression
and distribution of PCDH24 in HCM. After infection with
EHEC (106) for 8 or 18 hours, PCDH24 protein expression
was signiﬁcantly reduced (Figure 7B and Supplementary
Figure 2). Immunostaining of EHEC-infected monolayers
also showed signiﬁcant rearrangement of BB and lateral
membrane actin, and redistribution of PCDH24 from the BB
and the subapical compartment into intracellular vesicles
(see Figure 6C). However, expression levels of mucin-like
protocadherin (MLPCDH), a PCDH24 binding partner,
which together compose the intermicrovillar links,24 were
unaffected by EHEC, even after 18 hours of infection
(Supplementary Figure 3). Immunostaining of EHEC-infected
monolayers showed that MLPCDH is partially redistributed
Figure 5. Enterohemorr-
hagic Escherichia coli
(EHEC) forms attaching
and effacing (A/E) lesions
and actin pedestals while
also remodeling the
basolateral membranes.
(A) Scanning electron
microscope and (B) trans-
mission electron micro-
scope (TEM) images of
EHEC-infected differenti-
ated human colonoid
monolayers (HCM) after 8
hours. EHEC effaces the
microvilli and attaches via
actin pedestals (arrows,
inset of A). (C) EHEC at-
taches to the apical sur-
face of HCM via F-actin
pedestals. Note the over-
lapping actin with EHEC
(arrow). F-actin (red), EHEC
antigen (green), DNA
(blue). (D, E) TEM images
of (D) uninfected differen-
tiated HCM and (E) EHEC-
infected differentiated
HCM show that apical
infection with EHEC cau-
ses membrane perturba-
tion and actin remodeling
of both apical and baso-
lateral membranes. Note
that the apical tight junc-
tions were less affected by
EHEC infection.
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(Supplementary Figure 3). These data indicate that EHEC
speciﬁcally targets PCDH24 to cause microvillar damage.Enterohemorrhagic Escherichia coli Serine
Protease EspP Targets Protocadherin
24 and Causes Brush Border Effacement
Based on our previous study in which we found that the
EHEC serine protease EspP is essential for colonic BB actinremodeling,12 we hypothesized that EspP is responsible for
PCDH24 reduction and EHEC-induced microvillar efface-
ment. Indeed, infection of HCM with an isogenic EHEC strain
deleted for espP (EHECDespP, 106) for 18 hours did not
cause a decrease in the amount of PCDH24 (see Figure 7B).
Moreover, although wild-type EHEC caused F-actin blebbing
and severe damage to the BB and apical surface, infection
with EHECDespP did not cause any gross damage to the
BB (see Figure 7C), and the monolayer remained
virtually intact. The absence of severe damage to microvilli
Figure 6. EspP signiﬁcantly decreases the amount of protocadherin 24 (PCDH24) and remodels the brush border (BB).
(A) Representative image of normal human colonic tissue immunostained for PCDH24 shows that PCDH24 is localized to the
apical surface of colonocytes and to the brush border. Inset shows a zoomed-in section of the BB. PCDH24 (green), DNA
(blue). (B, C) PCDH24 expression on (B) uninfected and (C) enterohemorrhagic Escherichia coli (EHEC)–infected (8 hours)
human colonoid monolayers (HCM). PCDH24 is localized to the apical membrane of uninfected HCM and in intracellular
puncta of infected HCM. PCDH24 (green), F-actin (red), EHEC antigen (pink), DNA (blue). XY projection (top panels), XZ
projection (bottom panels).
58 In et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 1in EHECDespP-infected monolayers was not due to fewer
attached bacteria because bacterial counts from nine
random ﬁelds of view from infected monolayers (n ¼ 3)
showed that there were 56 ± 12/580 mm2 and 51 ± 14/580
mm2 EHEC and EHECDespP bacteria associated with the host
cells, respectively. Complementation of the EHECDespP
strain with a plasmid expressing the espP gene (see
Figure 7A) restored the bacterial EspP protein expression to
levels detected in the parental EHEC strain and also
restored the ability of the bacteria to target PCDH24 (see
Figure 7B), supporting our hypothesis that EspP is involved
in reduction of intermicrovillar bridges.
To further assess the role of EspP in PCDH24 reduction
and BB effacement, HCM were treated apically with puriﬁed
recombinant EspP. Recombinant EspP (added at a rate of
5 mg/hours) reduces PCDH24 in a time-dependent manner
(data not shown) with complete PCDH24 reduction seen
after 5 hours (see Figure 7B). Importantly, the serine pro-
tease activity of EspP was necessary for PCDH24 reduction
because the serine protease deﬁcient mutant, EspP S263A,
was unable to cleave PCDH24 (see Figure 7B). These results
show that the EHEC serine protease EspP contributes to BB
effacement by promoting reduction of the intermicrovillar
protein PCDH24.Enterohemorrhagic Escherichia coli Infection
Affects the Integrity of the Tight Junctions
It has been previously shown that EHEC infection caused
signiﬁcant decrease in TER and redistribution of several tight
junction (TJ) proteins, including occludin.32 Thus, we
analyzed the effect of EHEC infection on occludin distributionin colonoid monolayers. In differentiated uninfected HCM,
occludin was mainly present at the TJ (Figure 8A–C). In
contrast, occludin was redistributed from TJ into the cytosol
of HCM infected with EHEC for 18 hours (see Figure 8D–F).
EHEC infection also decreased the TER of colonoid mono-
layers (Table 1), although the TER decreases occurred 8
hours after infection; indicating that some claudins may be
affected by EHEC, correlating with a previous study that
found claudin-2 expression increases and causes increased
permeability after EHEC infection.32 Thus, our data from
EHEC-infected human colonoid monolayers are in good
agreement with previously published in vitro and in vivo
animal models.33,34Discussion
We have described an ex vivo human model for studying
intestinal host–pathogen interactions using stem
cell–derived HCM established from the proximal colon, the
site of EHEC disease in humans. These newly characterized
HCM provide a great advantage for the study of luminal
enteric infections compared to 3D Matrigel-embedded cul-
tures because each 3D colonoid is composed of a variable
number of cells and, owing to the topography, the apical
side is not directly accessible. Additionally, each 3D colonoid
lumen contains an unknown volume of ﬂuid that is subject
to sporadic expelling into the medium, jeopardizing
controlled measurements of host–pathogen interactions or
ﬁnal luminal concentration of the microbes, toxins, or
pharmacologic agents.
Monolayers allow for controlled access to both apical and
basolateral surfaces, thus facilitating highly reproducible
Figure 7. EspP signiﬁcantly decreases the amount of protocadherin 24 (PCDH24) and remodels the BB. (A) EspP
production was determined by Western blot analysis using a polyclonal EspP antiserum. EspP was detected in overnight
cultures of wild-type enterohemorrhagic Escherichia coli (EHEC) (lane 1), and the EHECDespP strain complemented with a
plasmid expressing espP (lane 3), but not in the culture of the EHECDespP strain (lane 2). (B) Expression of PCDH24
normalized to GAPDH is quantitated after infection by wild-type EHEC, mutant strain EHECDespP, or complemented espP
mutant strain (pespP), and after treatment (5 hours) by puriﬁed recombinant EspP or EspP S263A. *Statistically signiﬁcant
decrease compared with control (P < .05, n  3 per each condition). (C) Infection with wild-type EHEC, but not EHECDespP,
causes apical membrane perturbation and actin remodeling of the BB. F-actin (red), EHEC antigen (green), DNA (blue).
January 2016 Human Colonoids as a Model for EHEC Infection 59measurements of EHEC–colonic epithelial interactions. It was
recently shown that human intestinal enteroid monolayers
are a suitable model for EHEC infection.15 However, with the
exception of EHEC association with the ileal and rectal cul-
tures, no other aspects of EHEC-induced pathologies were
analyzed. Here, we provide the analysis of EHEC-induced
human proximal colonic disease at early times of infection
(0 to 8 hours), which has never beendescribed in patients due
to the asymptomatic phase of disease at this stage.
We determined that HCM can be differentiated in a
manner similar to the established protocols for 3D colonoid
cultures.13,22 Our data indicate that colonic differentiation
signiﬁcantly facilitates EHEC colonization. Impaired bacte-
rial colonization in the absence of mucus, as observed with
undifferentiated colonoids and differentiated jejunal mono-
layers, suggests that mucus may serve as an initial anchor
and a vital source of energy for EHEC, contributing to sur-
vival in the colonic lumen.
Our data show that the MUC2-positive inner mucus
layer, which creates a protective barrier between luminal
content, commensal bacteria, and the colonic epithelium, is
rapidly (<6 hours) reduced by EHEC. The role of humancolonic mucus in EHEC colonization is just emerging.
Recently it was shown that EHEC pathogenicity and meta-
bolism is positively modulated by consumption of fucose
derived from the mucus layer of transformed intestinal
epithelial HT-29 cells.35 These data are supported by studies
from the interaction of EHEC with bovine intestine. EHEC
rapidly cleaves and consumes carbohydrates from bovine
mucus, which promotes EHEC growth in the bovine intes-
tine that enables EHEC to compete with commensal E. coli.36
It has yet to be determined whether EHEC glycoside hy-
drolases, which catabolize monosaccharides and di-
saccharides of bovine mucus,36 are similarly involved in
human colonic mucus degradation. Interestingly, the EHEC
O157:H7 ﬂagella has been found to possess adhesive
properties and to bind to bovine mucus, particularly the
mucins MUC1 and MUC2.37 This interaction between the
colon’s inner mucus layer and the bacterial H7 ﬂagella may
represent an early step of EHEC attachment to the human
epithelium before intimate attachment by the T3SS and may
contribute to colonization.
The most recognized feature of EHEC infection is A/E
lesions of the microvilli. Here, using transmission electron
Figure 8. Enterohemorr-
hagic Escherichia coli
(EHEC) causes redistribu-
tion of occludin from tight
junctions to cytosolic
puncta. (A–C) Occludin is
localized to the lateral
membrane of uninfected
differentiated human colo-
noid monolayers (HCM).
Occludin (red), DNA (blue).
(A, B) XY projection; (C)
XZ projection. (D–F) EHEC
infection (18 hours) of HCM
causes occludin redistribu-
tion to cytosolic puncta and
signiﬁcant loss from the
tight junction. Occludin (red),
EHEC antigen (green), DNA
(blue). (D, E) XY projection;
(F) XZ projection.
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microscopy, we showed the formation of A/E lesions on
infected HCM surfaces. However, the epithelial damage was
not restricted solely to areas of EHEC attachment; rather, it
was a common overall feature of infected HCM. This in-
dicates that, in addition to the T3SS, EHEC use other
mechanisms of epithelial damage, including damage to the
BB and the TJ protein occludin. Our observations are in
agreement with a recent discovery that the tips of adjacent
microvilli are connected by bridges composed of PCDH24
and MLPCDH heterodimers, which play a critical role in
assembly and organization of BB.24 These proteins are
readily exposed to luminal contents, including bacterial
virulence factors. Interestingly, the EHEC-secreted serine
protease EspP is responsible for the reduction in PCDH24
but not MLPCDH, leading to destruction of the bridges and
BB disorganization.The importance of bacterial SPATEs secreted by the type
V secretion system in promoting Shiga toxin-producing
E. coli colonization is not well understood. Sequence ana-
lyses of the Shiga toxin-producing E. coli strain of enter-
oaggregative E. coli (EAEC) O104:H4 that caused the severe
2011 outbreak in Germany revealed that it encodes three
serine proteases: SepA, SigA, and Pic.38 The importance of
these proteases in enteroaggregative E. coli–induced disease
is controversial, with one study suggesting that they are
dispensable for intestinal colonization,39 while another
reporting that these proteases are essential for IEC coloni-
zation and Stx translocation.40 We and others have previ-
ously shown that the EHEC serine protease EspP is a
powerful virulence factor that plays an important role in
EHEC pathogenesis9 by causing microvillar remodeling and
formation of F-actin–coated macropinosomes.12 However,
the mammalian targets of EspP that lead to BB remodeling
January 2016 Human Colonoids as a Model for EHEC Infection 61are not well deﬁned. We now show that active EspP is
necessary and sufﬁcient for initial microvillar effacement
though the reduction in PCDH24. Whether EspP cleaves
PCDH24 directly or acts by an indirect mechanism remains
to be determined.
In conclusion, HCM provide an ideal, pathophysiologi-
cally relevant model to study the early molecular events in
intestinal epithelial colonization by EHEC; an area of study
that has been limited due to the use of transformed colonic
lines or animal models. Mucins, particularly MUC2 and the
BB protein PCDH24, are two initial targets of EHEC in host
colonization and microvillar effacement. The use of HCM for
further host–EHEC studies will likely provide new targets of
EHEC infection.
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Supplementary Figure 2. Conﬁrmation of protocadherin
24 (PCDH24) reduction by EspP. PCDH24 expression is
signiﬁcantly decreased with enterohemorrhagic Escherichia
coli (EHEC) or EHECDstcE, but minimally with EHECDespP
infection. Lower molecular weight, or cleaved, forms of
PCDH24 are not detected, possibly due to the lack of antigen
recognition by the antibody used.
Supplementary Figure 1. Differentiation results in a
decrease of the stem cell marker leucine-rich repeat
containing G protein-coupled receptor 5 (LGR5). Relative
LGR5 expression was measured by semiquantitative poly-
merase chain reaction in three different human colonoid lines
(undifferentiated and differentiated for 5 days). LGR5 was
normalized to RN18S and relative expression levels from the
three colonoid lines were averaged. Average LGR5 expres-
sion was 877.4 ± 157.9 and 9.9 ± 3.5 in undifferentiated and
differentiated, respectively. *Statistically signiﬁcant decrease
of LGR5 expression, P < .05, n ¼ 5.
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Supplementary Figure 3. (See previous page). Mucin-like protocadherin (MLPCDH), a protocadherin 24 (PCDH24)
binding partner, is mislocalized, but protein expression level does not change upon enterohemorrhagic Escherichia
coli (EHEC) infection. Representative immunoblot of MLPCDH in control and infected human colonoid monolayers. The
MLPCDH expression level does not change upon EHEC infection (up to 18 hours) or treatment with recombinant EspP (10 mM,
60 minutes). (A) Representative image of a differentiated colonoid monolayer immunostained for MLPCDH (red, left panel),
actin (phalloidin, white, middle panel), and overlayed in the right panel; DNA (Hoechst, blue). Note that MLPCDH is mainly on
the apical surface and overlaps with the actin pattern. (B) Representative image of an EHEC-infected differentiated colonoid
monolayer immunostained for actin (phalloidin, white), MLPCDH (red), EHEC antigen (green), and DNA (Hoechst, blue). Overlay
in the XY plane is shown on the left panel. XZ planes (right panels) show that MLPCDH becomes mislocalized from the BB into
the cytosol.
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